Mochida Pharmaceutical has patented a ready-to-use sterile alginate aqueous solution with storage stability, containing low-endotoxin monovalent metal salt of alginic acid. The solution is packed in sealed containers and has specific concentration and viscosity requirements. GlobalData’s report on Mochida Pharmaceutical gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Mochida Pharmaceutical, Cancer treatment biomarkers was a key innovation area identified from patents. Mochida Pharmaceutical's grant share as of May 2024 was 34%. Grant share is based on the ratio of number of grants to total number of patents.
Ready-to-use sterile alginate aqueous solution preparation with storage stability
The patent (Publication Number: US11969437B2) discloses a ready-to-use sterile alginate aqueous solution preparation with storage stability, packed in a sealed or airtight container. The solution consists of components including a monovalent metal salt of alginic acid, a salt selected from monovalent metal or ammonium salt, and water. The concentration of the components and the viscosity of the solution are specified within the claims. The solution is intended for use as a pharmaceutical or medical device, with specific requirements for storage temperature and viscosity decrease rates over time.
Furthermore, the patent details methods of producing the alginate aqueous solution preparation, involving sterically or aseptically filtering an aqueous solution of monovalent metal alginate, filling a container with the filtrate, and sealing it after concentration or freeze-drying. The patent also mentions variations in the average molecular weight and concentration of the components that the solution can meet, along with the option of using pre-filled syringes as containers. The emphasis is on ensuring the quality, stability, and sterility of the alginate solution for pharmaceutical or medical applications, with specific parameters outlined for production and storage conditions to maintain its efficacy.
To know more about GlobalData’s detailed insights on Mochida Pharmaceutical, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
